Upgrade to SI Premium - Free Trial

NewAmsterdam Pharma Co NV (NAMS) PT Lowered to $50 at RBC Capital

August 6, 2026 6:52 AM
RBC Capital analyst Leonid Timashev lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change